Additionally, activated leukocyte cell adhesion molecule (ALCAM/CD166), the known ligand for CD6 domain 3, is over-expressed in blood brain barrier cells within the central nervous system of MS patients and in experimental autoimmune encephalomyelitis lesions [16]. This evidence concerns the gene ALCAM and myeloid sarcoma.